Kevin R. Sayer

Kevin R. Sayer

Chairperson, President & Chief Executive OfficeratDexcom· In proxies 2021–2025

Pay in FY2023+2% from the year before · Dexcom stock +9.6% the same year

Kevin R. Sayer was paid $15.7M in FY2023 (Dec), up 2%. Dexcom stock rose 9.6% that year.

Pay$100 in the stock at the end of FY20 → $134
Pay is from the Summary Compensation Table of each Dexcom proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. DexcomPublic company · 5 yr
    • Chairperson, President & Chief Executive Officer2021 – Present · 5 yrStock in role -11%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?